The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Raha, Animesh Alexander ^a,c   Vaishnav, Radhika Anand ^b   Friedland, Robert Paul ^b   Bomford, Adrian ^c   Raha Chowdhury, Ruma ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b University of Louisville School of Medicine   (United States)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid; Brain iron homeostasis; Ferritin; Neurodegeneration; Vascular endothelium damage

Indexed keywords

EID: 85005921759     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/2051-5960-1-55     Document Type: Article

References (107)

1. Zlokovic BV: The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008,57(2):178-201. 10.1016/j.neuron.2008.01.003
2. Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV: Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol 2013,23(3):303-310. 10.1111/bpa.12004
3. Shi J, Perry G, Smith MA, Friedland RP: Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 2000,21(2):357-361. 10.1016/S0197-4580(00)00119-6
4. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M: Alpha-synuclein in Lewy bodies. Nature 1997,388(6645):839-840. 10.1038/42166
5. Goedert M, Spillantini MG: A century of Alzheimer's disease. Science 2006,314(5800):777-781. 10.1126/science.1132814
6. Bayer TA, Wirths O: Intraneuronal Abeta as a trigger for neuron loss: can this be translated into human pathology? Biochem Soc Trans 2011,39(4):857-861. 10.1042/BST0390857
7. Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992,256(5054):184-185. 10.1126/science.1566067
8. Selkoe DJ: Clearing the brain's amyloid cobwebs. Neuron 2001,32(2):177-180. 10.1016/S0896-6273(01)00475-5
9. Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC: Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 1987,235(4791):873-877. 10.1126/science.3544219
10. Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002,297(5580):353-356. 10.1126/science.1072994
11. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ: Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008,14(8):837-842. 10.1038/nm1782
12. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993,261(5123):921-923. 10.1126/science.8346443
13. Mahley RW, Weisgraber KH, Huang Y: Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 2006,103(15):5644-5651. 10.1073/pnas.0600549103
14. Kalaria RN, Cohen DL, Premkumar DR: Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease. Ann N Y Acad Sci 1996, 777: 266-270. 10.1111/j.1749-6632.1996.tb34430.x
15. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN: Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996,148(6):2083-2095.
16. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM: Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A 1985,82(1):203-207. 10.1073/pnas.82.1.203
17. Ang LS, Cruz RP, Hendel A, Granville DJ: Apolipoprotein E, an important player in longevity and age-related diseases. Exp Gerontol 2008,43(7):615-622. 10.1016/j.exger.2008.03.010
18. Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R, Zlokovic BV: Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 2007,27(5):909-918.
19. Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV: apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 2008,118(12):4002-4013. 10.1172/JCI36663
20. Martel CL, Mackic JB, Matsubara E, Governale S, Miguel C, Miao W, McComb JG, Frangione B, Ghiso J, Zlokovic BV: Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. J Neurochem 1997,69(5):1995-2004.
21. Raven EP, Lu PH, Tishler TA, Heydari P, Bartzokis G: Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected In vivo with magnetic resonance imaging. J Alzheimers Dis 2013,37(1):127-136.
22. Grundke-Iqbal I, Fleming J, Tung YC, Lassmann H, Iqbal K, Joshi JG: Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol 1990,81(2):105-110. 10.1007/BF00334497
23. Todorich BM, Connor JR: Redox metals in Alzheimer's disease. Ann N Y Acad Sci 2004, 1012: 171-178. 10.1196/annals.1306.014
24. Smith MA, Perry G, Pryor WA: Causes and consequences of oxidative stress in Alzheimer's disease. Free Radic Biol Med 2002,32(11):1049. 10.1016/S0891-5849(02)00793-1
25. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR: Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004,5(11):863-873.
26. Bishop GM, Robinson SR: Human Abeta1-42 reduces iron-induced toxicity in rat cerebral cortex. J Neurosci Res 2003,73(3):316-323. 10.1002/jnr.10661
27. Atamna H: Heme binding to Amyloid-beta peptide: mechanistic role in Alzheimer's disease. J Alzheimers Dis 2006,10(2-3):255-266.
28. Bergamini E, Bizzarri R, Cavallini G, Cerbai B, Chiellini E, Donati A, Gori Z, Manfrini A, Parentini I, Signori F, Tamburini I: Ageing and oxidative stress: a role for dolichol in the antioxidant machinery of cell membranes? J Alzheimers Dis 2004,6(2):129-135.
29. Smith MA, Harris PL, Sayre LM, Perry G: Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 1997,94(18):9866-9868. 10.1073/pnas.94.18.9866
30. Ganz T: Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003,102(3):783-788. 10.1182/blood-2003-03-0672
31. Ganz T: Hepcidin and iron regulation, 10 years later. Blood 2011,117(17):4425-4433. 10.1182/blood-2011-01-258467
32. Yang F, Liu XB, Quinones M, Melby PC, Ghio A, Haile DJ: Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J Biol Chem 2002,277(42):39786-39791. 10.1074/jbc.M201485200
33. McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A, Peters TJ, Raja KB, Shirali S, Hediger MA, Farzaneh F, Simpson RJ: An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 2001,291(5509):1755-1759. 10.1126/science.1057206
34. Hentze MW, Muckenthaler MU, Galy B, Camaschella C: Two to tango: regulation of Mammalian iron metabolism. Cell 2010,142(1):24-38. 10.1016/j.cell.2010.06.028
35. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004,306(5704):2090-2093. 10.1126/science.1104742
36. De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, Musci G, Kaplan J: Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J 2007,26(12):2823-2831. 10.1038/sj.emboj.7601735
37. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K: LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000,480(2-3):147-150.
38. Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001,276(11):7806-7810. 10.1074/jbc.M008922200
39. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O: A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001,276(11):7811-7819. 10.1074/jbc.M008923200
40. Cheng PP, Jiao XY, Wang XH, Lin JH, Cai YM: Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med 2011,11(1):33-42. 10.1007/s10238-010-0102-9
41. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, Goldberg YP, Sakellaropoulos N, Ganz T, Nemeth E: Hepcidin in iron overload disorders. Blood 2005,105(10):4103-4105. 10.1182/blood-2004-12-4844
42. Abboud S, Haile DJ: A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000,275(26):19906-19912. 10.1074/jbc.M000713200
43. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ: A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000,5(2):299-309. 10.1016/S1097-2765(00)80425-6
44. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI: Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000,403(6771):776-781. 10.1038/35001596
45. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC: The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 2005,1(3):191-200. 10.1016/j.cmet.2005.01.003
46. Wu LJ, Leenders AG, Cooperman S, Meyron-Holtz E, Smith S, Land W, Tsai RY, Berger UV, Sheng ZH, Rouault TA: Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res 2004,1001(1-2):108-117.
47. Burdo JR, Menzies SL, Simpson IA, Garrick LM, Garrick MD, Dolan KG, Haile DJ, Beard JL, Connor JR: Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res 2001,66(6):1198-1207. 10.1002/jnr.1256
48. Moos T, Rosengren Nielsen T: Ferroportin in the postnatal rat brain: implications for axonal transport and neuronal export of iron. Semin Pediatr Neurol 2006,13(3):149-157. 10.1016/j.spen.2006.08.003
49. Moos T, Skjoerringe T, Gosk S, Morgan EH: Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J Neurochem 2006,98(6):1946-1958. 10.1111/j.1471-4159.2006.04023.x
50. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI: Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 2010,142(6):857-867. 10.1016/j.cell.2010.08.014
51. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996,274(5284):99-102. 10.1126/science.274.5284.99
52. Kumar-Singh S, Pirici D, McGowan E, Serneels S, Ceuterick C, Hardy J, Duff K, Dickson D, Van Broeckhoven C: Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. Am J Pathol 2005,167(2):527-543. 10.1016/S0002-9440(10)62995-1
53. Chuang JY, Lee CW, Shih YH, Yang T, Yu L, Kuo YM: Interactions between amyloid-beta and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease. PLoS One 2012,7(3):e33120. 10.1371/journal.pone.0033120
54. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D: Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci 1996,16(18):5795-5811.
55. Winkler EA, Sengillo JD, Bell RD, Wang J, Zlokovic BV: Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. J Cereb Blood Flow Metab 2012,32(10):1841-1852. 10.1038/jcbfm.2012.113
56. Zhao JW, Raha-Chowdhury R, Fawcett JW, Watts C: Astrocytes and oligodendrocytes can be generated from NG2+ progenitors after acute brain injury: intracellular localization of oligodendrocyte transcription factor 2 is associated with their fate choice. Eur J Neurosci 2009,29(9):1853-1869. 10.1111/j.1460-9568.2009.06736.x
57. Raha-Chowdhury R, Andrews SR, Gruen JR: CAT 53: a protein phosphatase 1 nuclear targeting subunit encoded in the MHC Class I region strongly expressed in regions of the brain involved in memory, learning, and Alzheimer's disease. Brain Res Mol Brain Res 2005,138(1):70-83. 10.1016/j.molbrainres.2005.04.001
58. Burgess A, Vigneron S, Brioudes E, Labbe JC, Lorca T, Castro A: Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci U S A 2010,107(28):12564-12569. 10.1073/pnas.0914191107
59. Crews L, Adame A, Patrick C, Delaney A, Pham E, Rockenstein E, Hansen L, Masliah E: Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis. J Neurosci 2010,30(37):12252-12262. 10.1523/JNEUROSCI.1305-10.2010
60. Cullen KM, Kocsi Z, Stone J: Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex. J Cereb Blood Flow Metab 2005,25(12):1656-1667. 10.1038/sj.jcbfm.9600155
61. Schneider SA, Hardy J, Bhatia KP: Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations. Mov Disord 2012,27(1):42-53. 10.1002/mds.23971
62. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA: Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001,60(8):759-767.
63. Bonda DJ, Lee HG, Blair JA, Zhu X, Perry G, Smith MA: Role of metal dyshomeostasis in Alzheimer's disease. Metallomics 2011,3(3):267-270. 10.1039/c0mt00074d
64. Ding H, Yan CZ, Shi H, Zhao YS, Chang SY, Yu P, Wu WS, Zhao CY, Chang YZ, Duan XL: Hepcidin is involved in iron regulation in the ischemic brain. PLoS One 2011,6(9):e25324. 10.1371/journal.pone.0025324
65. Li H, Rose MJ, Tran L, Zhang J, Miranda LP, James CA, Sasu BJ: Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. J Pharmacol Toxicol Methods 2009,59(3):171-180. 10.1016/j.vascn.2009.02.004
66. Andersen MV, PRg C, Jensen MD, Lichota J, Moos T: A decrease in neuronal ferroportin accompanies chronic brain inflammation with iron deposition. Meeting of the International BioIron Society 2013.
67. Malik IA, Naz N, Sheikh N, Khan S, Moriconi F, Blaschke M, Ramadori G: Comparison of changes in gene expression of transferrin receptor-1 and other iron-regulatory proteins in rat liver and brain during acute-phase response. Cell Tissue Res 2011,344(2):299-312. 10.1007/s00441-011-1152-3
68. Rathore KI, Redensek A, David S: Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-alpha and TGF-beta1. Glia 2012,60(5):738-750. 10.1002/glia.22303
69. Urrutia P, Aguirre P, Esparza A, Tapia V, Mena NP, Arredondo M, Gonzalez-Billault C, Nunez MT: Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem 2013,126(4):541-549. 10.1111/jnc.12244
70. Liu XB, Nguyen NB, Marquess KD, Yang F, Haile DJ: Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells Mol Dis 2005,35(1):47-56. 10.1016/j.bcmd.2005.04.006
71. Ludwiczek S, Aigner E, Theurl I, Weiss G: Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003,101(10):4148-4154. 10.1182/blood-2002-08-2459
72. Sheikh N, Dudas J, Ramadori G: Changes of gene expression of iron regulatory proteins during turpentine oil-induced acute-phase response in the rat. Lab Invest 2007,87(7):713-725. 10.1038/labinvest.3700553
73. Iadecola C: The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 2010,120(3):287-296. 10.1007/s00401-010-0718-6
74. Zlokovic BV: Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 2011,12(12):723-738.
75. Eikelenboom P, Hoozemans JJ, Veerhuis R, van Exel E, Rozemuller AJ, van Gool WA: Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease. Alzheimer's Res Ther 2012,4(3):1-9.
76. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, et al.: Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 1992,89(21):10016-10020. 10.1073/pnas.89.21.10016
77. Grammas P: Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation 2011, 8: 26. 10.1186/1742-2094-8-26
78. Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D: Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther 2010,2(1):1. 10.1186/alzrt24
79. Li L, Holscher C, Chen BB, Zhang ZF, Liu YZ: Hepcidin treatment modulates the expression of divalent metal transporter-1, ceruloplasmin, and ferroportin-1 in the rat cerebral cortex and hippocampus. Biol Trace Elem Res 2011,143(3):1581-1593. 10.1007/s12011-011-8967-3
80. Wang SM, Fu LJ, Duan XL, Crooks DR, Yu P, Qian ZM, Di XJ, Li J, Rouault TA, Chang YZ: Role of hepcidin in murine brain iron metabolism. Cell Mol Life Sci 2010,67(1):123-133. 10.1007/s00018-009-0167-3
81. Pietrangelo A, Dierssen U, Valli L, Garuti C, Rump A, Corradini E, Ernst M, Klein C, Trautwein C: STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 2007,132(1):294-300. 10.1053/j.gastro.2006.10.018
82. Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B: Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 1992,66(2):223-230.
83. Pietrangelo A: Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010,139(2):393-408. 408 e1-2 10.1053/j.gastro.2010.06.013
84. Moos T, Trinder D, Morgan EH: Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain. Cell Mol Biol (Noisy-le-grand) 2000,46(3):549-561.
85. Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN: Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 2009,50(6):1992-2000. 10.1002/hep.23198
86. Zechel S, Huber-Wittmer K, von Bohlen und Halbach O: Distribution of the iron-regulating protein hepcidin in the murine central nervous system. J Neurosci Res 2006,84(4):790-800. 10.1002/jnr.20991
87. Bulet P, Stocklin R, Menin L: Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev 2004, 198: 169-184. 10.1111/j.0105-2896.2004.0124.x
88. Drin G, Cottin S, Blanc E, Rees AR, Temsamani J: Studies on the internalization mechanism of cationic cell-penetrating peptides. J Biol Chem 2003,278(33):31192-31201. 10.1074/jbc.M303938200
89. Kumagai AK, Eisenberg JB, Pardridge WM: Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem 1987,262(31):15214-15219.
90. Deguchi Y, Naito T, Yuge T, Furukawa A, Yamada S, Pardridge WM, Kimura R: Blood-brain barrier transport of 125I-labeled basic fibroblast growth factor. Pharm Res 2000,17(1):63-69. 10.1023/A:1007570509232
91. Triguero D, Buciak J, Pardridge WM: Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem 1990,54(6):1882-1888. 10.1111/j.1471-4159.1990.tb04886.x
92. Connor JR, Menzies SL, St Martin SM, Mufson EJ: A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 1992,31(1):75-83. 10.1002/jnr.490310111
93. Goodman L: Alzheimer's disease: a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J Nerv Ment Dis 1953,118(2):97-130. 10.1097/00005053-195308000-00001
94. Falangola MF, Lee SP, Nixon RA, Duff K, Helpern JA: Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice. Neurochem Res 2005,30(2):201-205. 10.1007/s11064-004-2442-x
95. Good PF, Perl DP, Bierer LM, Schmeidler J: Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 1992,31(3):286-292. 10.1002/ana.410310310
96. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR: Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998,158(1):47-52. 10.1016/S0022-510X(98)00092-6
97. Bush AI: The metal theory of Alzheimer's disease. J Alzheimers Dis 2013,33(Suppl 1):S277-S281.
98. Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ: Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 1992,31(2):327-335. 10.1002/jnr.490310214
99. Loeffler D, Connor J, Juneau P, Snyder B, Kanaley L, DeMaggio A, Nguyen H, Brickman C, LeWitt P: Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem 1995,65(2):710-716.
100. Yu X, Du T, Song N, He Q, Shen Y, Jiang H, Xie J: Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease. Neurology 2013,80(5):492-495. 10.1212/WNL.0b013e31827f0ebb
101. Grundke-Iqbal I, Fleming J, Tung Y-C, Lassmann H, Iqbal K, Joshi J: Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta neuropathologica 1990,81(2):105-110. 10.1007/BF00334497
102. Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB: Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm Park Dis Dement Sect 1990,2(4):327-340. 10.1007/BF02252926
103. Li X, Liu Y, Zheng Q, Yao G, Cheng P, Bu G, Xu H, Zhang YW: Ferritin light chain interacts with PEN-2 and affects gamma-secretase activity. Neurosci Lett 2013, 548: 90-94.
104. Connor JR, Boeshore KL, Benkovic SA, Menzies SL: Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res 1994,37(4):461-465. 10.1002/jnr.490370405
105. Winkler EA, Bell RD, Zlokovic BV: Central nervous system pericytes in health and disease. Nat Neurosci 2011,14(11):1398-1405. 10.1038/nn.2946
106. Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM: Vascular beta-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAbeta mice. Acta Neuropathol 2011,122(3):293-311. 10.1007/s00401-011-0834-y
107. Morris CM, Kerwin JM, Edwardson JA: Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. Neurodegeneration 1994,3(4):267-275.